跳至主要内容
临床试验/CTRI/2025/08/093784
CTRI/2025/08/093784尚未招募2/3 期

Prospective trial to evaluate acute toxicity during post operative radiotherapy after flap reconstructive surgery in head and neck cancer patients undergoing volumetric modulated ARC therapy

PGIMER CHANDIGARH1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年10月22日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
50
试验地点
1
主要终点
1.To evaluate acute toxicity (mucositis, dysphagia, dermatitis, xerostomia, dysgeusia, anorexia, nausea, vomiting, pain) of postoperative radiotherapy between SIB- VMAT and non SIB- VMAT treatment technique during treatment and at 3 months follow up.

研究概览

简要总结

The current practice of Post operative radiotherapy in Head and Neck cancer involves radiation of the entire flap in treatment portal. This leads to a considerable increase in radiotherapy treatment volume. As a consequence, there is significant acute toxicity associated with treatment and associated flap changes. Recent literature and guidelines have recommended to include only the flap junctional area in high-risk treatment volume. The rest of flap can be included in the low dose radiotherapy treatment volume.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Biopsy proven Squamous cell carcinoma of oral cavity and paranasal sinus.
  • 2.Adult patients undergoing surgery with flap reconstruction and post operative radiotherapy.
  • 3.Patients requiring post operative radiotherapy for any of the following indications: T3N0M0, T1-3N1,2M0, T4aN2M0, AnyTN3M0 disease.
  • 4.Patient requiring postoperative radiotherapy due to positive margin, close margin, extra nodal extension in Post Operative Histopathology Report.
  • Patients giving written consent for study and follow up.

排除标准

  • 1.Patient being treated for recurrent head and neck cancer.
  • 2.Patient with uncontrolled comorbidities like diabetes mellitus and hypertension.
  • 3.Previous history of undergoing head and neck radiotherapy.

结局指标

主要结局

1.To evaluate acute toxicity (mucositis, dysphagia, dermatitis, xerostomia, dysgeusia, anorexia, nausea, vomiting, pain) of postoperative radiotherapy between SIB- VMAT and non SIB- VMAT treatment technique during treatment and at 3 months follow up.

时间窗: 1.During treatment | 2. At 3 months follow up.

次要结局

  • To evaluate incidence of flap complications- infection, mild dehiscence, bone exposure, fistula, hematoma, partial flap loss, complete flap loss)between SIB- VMAT and non SIB- VMAT treatment technique during treatment and at 3 months follow up.(2. To evaluate disease recurrence between the study groups at a minimum of three months follow up.)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

PROF AMIT BAHL

PGIMER, CHANDIGARH

研究点 (1)

Loading locations...

相似试验